Posted by Couleuvre on July 3, 2019, at 8:10:30
In reply to Re: why, posted by Lamdage22 on July 3, 2019, at 7:29:54
Believe-it-or-not, me-toos can be a good thing in moderation! Like, if you get a certain side effect on one SSRI the you can try another. Or if you want a longer- or shorter-acting benzo, or one that starts working faster, or whatever, there are lots (LOTS) of different ones you can try.
OTOH, there does need to be more focus on new research. There's some hope that the approval of esketamine will spark research. Esketamine is a "dirty" drug: it has lots of different pharmacodynamic effects on different receptor types & subtypes. Most researchers seem to be fixated on a particular receptor (glutamate NMDA receptor) as the likely cause for its fast-acting antidepressant effect, but it would be nice to see this new use for an what had been considered an unusual anaesthetic and club drug spawning research on the many other receptors and things it targets.
-Couleuvre
poster:Couleuvre
thread:1104909
URL: http://www.dr-bob.org/babble/20190513/msgs/1105118.html